|
ZNF772 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22519999999449E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.168050E-04 |
| Normal-vs-Stage2 |
3.836500E-03 |
| Normal-vs-Stage3 |
3.27629999996581E-06 |
| Normal-vs-Stage4 |
1.36350000001784E-06 |
| Stage1-vs-Stage2 |
7.208600E-01 |
| Stage1-vs-Stage3 |
9.657600E-02 |
| Stage1-vs-Stage4 |
5.350200E-02 |
| Stage2-vs-Stage3 |
1.549040E-01 |
| Stage2-vs-Stage4 |
7.330000E-02 |
| Stage3-vs-Stage4 |
5.349400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51459999999859E-05 |
| Normal-vs-AfricanAmerican |
1.306110E-02 |
| Normal-vs-Asian |
5.204600E-04 |
| Caucasian-vs-AfricanAmerican |
7.037000E-01 |
| Caucasian-vs-Asian |
6.650200E-01 |
| AfricanAmerican-vs-Asian |
9.522000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.35370000000779E-05 |
| Normal-vs-Female |
2.24659999999988E-05 |
| Male-vs-Female |
8.058800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.68369999999608E-05 |
| Normal-vs-Age(41-60Yrs) |
2.05349999999882E-05 |
| Normal-vs-Age(61-80Yrs) |
3.36590000005188E-06 |
| Normal-vs-Age(81-100Yrs) |
3.200400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.577400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.789600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.167000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.541770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.202200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.791000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.818500E-04 |
| Classical-VS-Follicular |
2.309000E-01 |
| Classical-VS-Other |
6.731600E-01 |
| Classical-VS-Normal |
2.771500E-04 |
| Tall-VS-Follicular |
4.252400E-02 |
| Tall-VS-Other |
4.502400E-01 |
| Tall-VS-Normal |
7.67440000437603E-08 |
| Follicular-VS-Other |
9.925200E-01 |
| Follicular-VS-Normal |
5.53959999999298E-05 |
| Other-VS-Normal |
7.782100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65725999999866E-05 |
| Normal-vs-N1 |
3.55129999995984E-06 |
| N0-vs-N1 |
9.372200E-02 |
|
|
